Amass and SciSure partner to bring scientific AI into laboratory workflows worldwide

‍Copenhagen, Denmark, October 5, 2026 — Amass and SciSure today announce a partnership to integrate Amass’s scientific intelligence into SciSure’s Scientific Management Platform, beginning within its electronic laboratory notebook. The integration connects researchers’ own experiments with external scientific evidence, enabling them to investigate results, challenge hypotheses and explore next steps within their existing research workflow.

For Amass, the partnership opens a route into SciSure’s global laboratory community and advances its strategy of embedding scientific intelligence in the software researchers use every day. SciSure brings research documentation, laboratory operations and safety into a shared platform; Amass adds the ability to investigate scientific questions using both experiment context and connected external evidence.

Amass’s *Core architecture connects literature, patents, clinical trials, regulatory information, drugs and genes. Researchers can follow a question across these domains in one conversation, inspect cited sources and pursue new lines of enquiry as the evidence develops.

Within SciSure, a researcher can select experiments and ask Amass to review relevant literature, compare published findings or investigate possible explanations for an unexpected result. Follow-up questions can test an interpretation or explore evidence that challenges it, while additional experiments can extend the investigation.

“We are building Amass to bring scientific intelligence into the work researchers do every day. With SciSure, a scientist can start with an experiment already in their notebook and investigate how it connects to the wider evidence. This partnership gives us a route to bring that capability to laboratories around the world,” said Henrik Jensen, Co-founder and CEO of Amass.

Researchers control the experiment context they share. They can select up to five experiments, preview the text, choose individual sections and optionally mask compound identifiers before sending a question to Amass. The integration uses selected experiment text; attachments and images are excluded.

“We want SciSure to be the home base where laboratories connect their research, data and the specialized tools that help move science forward. Opening our platform to innovative partners like Amass is central to that vision. By bringing scientific intelligence directly into the researcher’s existing workflow, we can help scientists put their experimental results into broader context, evaluate the evidence and make more informed decisions about what comes next,” said Andrew Martin, Director/GM of Marketplace and Integrations at SciSure.

The partnership brings together Amass’s connected scientific evidence infrastructure with SciSure’s established laboratory workflows, giving researchers a more direct way to move between their own experimental work and relevant external evidence. It also reflects both companies’ focus on embedding specialized capabilities into the tools scientists already use, rather than requiring researchers to move between disconnected systems. 

About Amass

Amass is a Copenhagen-based company building scientific intelligence infrastructure for life sciences. Its connected *Core architecture brings together life science data such as literature, patents, clinical trials, regulatory information, drugs and genes, alongside live external sources as an embedded intelligence layer. Researchers use Amass to investigate complex questions, examine evidence and monitor developments. Available through its application, APIs and integrations, Amass brings cited scientific research into the workflows where teams plan experiments and make decisions.

https://amass.tech

Media contacts

Amass: Henrik Jensen, Co-founder and CEO | hj@amass.tech

SciSure: Andrew Martin, Director/GM of Marketplace and Integrations | a.martin@scisure.com

‍